Maria Francesca Secchi
Overview
Explore the profile of Maria Francesca Secchi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
216
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Montano-Loza A, Ronca V, Ebadi M, Hansen B, Hirschfield G, Elwir S, et al.
J Hepatol
. 2022 Feb;
77(1):84-97.
PMID: 35143897
Background & Aims: Autoimmune hepatitis can recur after liver transplantation (LT), though the impact of recurrence on patient and graft survival has not been well characterized. We evaluated a large,...
2.
Floreani A, Restrepo-Jimenez P, Secchi M, De Martin S, Leung P, Krawitt E, et al.
J Autoimmun
. 2018 Nov;
95:133-143.
PMID: 30385083
Autoimmune hepatitis is a chronic inflammatory liver disease characterized by hypergammaglobulinemia, the presence of autoantibodies, and inflammation within the liver, including lymphocytic infiltrates and interface hepatitis. Autoimmune hepatitis shows a...
3.
Floreani A, De Martin S, Secchi M, Cazzagon N
Eur J Intern Med
. 2018 Oct;
59:1-7.
PMID: 30360943
The most important autoimmune liver disease include: autoimmune hepatitis, primary biliary cholangitis and primary sclerosing cholangitis. In general, about one in three patients with an autoimmune liver disease have a...
4.
Secchi M, Torre C, Dui G, Virdis F, Podda M
Case Rep Surg
. 2018 Aug;
2018:8020197.
PMID: 30123608
Colonoscopic perforation is a serious and potentially life-threatening complication of colonoscopy. Its incidence varies in frequency from 0.016% to 0.21% for diagnostic procedures, but may be seen in up to...
5.
Secchi M, Crescenzi M, Masola V, Russo F, Floreani A, Onisto M
Sci Rep
. 2017 Nov;
7(1):14956.
PMID: 29097791
The heparan sulfate endoglycosidase heparanase (HPSE) is involved in tumor growth, chronic inflammation and fibrosis. Since a role for HPSE in chronic liver disease has not been demonstrated to date,...
6.
Masola V, Zaza G, Bellin G, DallOlmo L, Granata S, Vischini G, et al.
FASEB J
. 2017 Oct;
32(2):742-756.
PMID: 28970256
Heparanase (HPSE) is part of the biologic network triggered by ischemia/reperfusion (I/R) injury, a complication of renal transplantation and acute kidney injury. During this period, the kidney or graft undergoes...
7.
Secchi M, Masola V, Zaza G, Lupo A, Gambaro G, Onisto M
Biomol Concepts
. 2015 Nov;
6(5-6):415-21.
PMID: 26552066
Heparanase (HPSE) is a multitasking protein characterized by enzymatic and non-enzymatic activities. By means of its enzymatic activity, HPSE catalyzes the cutting of the side chains of heparan sulfate (HS)...
8.
Masola V, Zaza G, Secchi M, Gambaro G, Lupo A, Onisto M
Biochim Biophys Acta
. 2014 Jun;
1843(9):2122-8.
PMID: 24937189
Epithelial-mesenchymal transition (EMT) of tubular cells is one of the mechanisms which contribute to renal fibrosis and transforming growth factor-β (TGF-β) is one of the main triggers. Heparanase (HPSE) is...
9.
Masola V, Secchi M, Gambaro G, Onisto M
Curr Cancer Drug Targets
. 2014 Feb;
14(3):286-93.
PMID: 24568197
Heparanase is the unique and specific functional endoglycosidase capable of cleaving heparan sulfate (HS) chains. It exerts its enzymatic activity catalyzing the cleavage of the β (1,4)-glycosidic bond between glucuronic...